![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Chapter
Bronchialkarzinom
Das Bronchialkarzinom zählt zu den häufigsten malignen Erkrankungen und ist die häufigste Krebstodesursache beim Mann mit 30 % aller Krebstodesfälle. Während bei Männern in bestimmten westlichen Ländern bereit...
-
Chapter
Bronchialkarzinom
Das Bronchialkarzinom ist der häufigste zum Tode führende Tumor des Mannes. Weltweit muss mit 1 Mio. Todesfällen/Jahr gerechnet werden. In der Bundesrepublik Deutschland verstarben im Jahre 1995 31.147 Persone...
-
Article
Long-term survival in small cell lung cancer patients is correlated with high interleukin-2 secretion at diagnosis
Purpose: We have previously reported significant impairment of IL-2 secretion in patients with small cell lung cancer (SCLC) at the time of diagnosis. Impairment of IL-2 secretion correlated with reduced surviva...
-
Chapter
Nichtkleinzellige Bronchialkarzinome
-
Chapter and Conference Paper
CYFRA 21-1 beim Bronchialkarzinom: Ergebnisse einer prospektiven Multicenterstudie
In einer prospektiven Multicenterstudie wurde bei 244 Patienten mit Bronchialkarzinom die diagnostische Bedeutung des neuen Tumor-markers CYFRA im Vergleich mit den etablierten Markern CEA, SCC und NSE untersu...
-
Article
Lectin-mediated pathways in activation of neutrophils from patients with lung cancer
-
Article
Sensitive detection of few vital small cell lung cancer (SCLC) cells in blood and sputum by RT-PCR
-
Article
CD44 variant expression in human lung cancer and normal bronchial epithelium
-
Chapter and Conference Paper
Different Cytokines with Autocrine and Immunosuppressive Activities are Secreted by a Small-Cell Lung Cancer Cell Line
In recent years, knowledge about growth control of solid tumors and lymphoid malignancies by soluble growth factors has increased considerably. Experimental evidence is accumulating which indicates that autocr...
-
Article
Abstract
-
Article
Effect of rhGM-CSF on haematopoietic reconstitution after chemotherapy in small-cell lung cancer
In three consecutive pilot studies the effect of recombinant human granulocyte/macrophage-colony-stimulating factor (rhGM-CSF) on haematopoetic recovery after chemotherapy in patients with small-cell lung canc...
-
Article
Absract
-
Article
Plasma glutamate levels, lymphocyte reactivity and death rate in patients with bronchial carcinoma
Elevated glutamate concentrations are commonly observed in patients with advanced carcinoma, and glutamate was recently found to inhibit the membrane transport of cystine and to impair the function of macropha...
-
Article
The role of ifosfamide and cyclophosphamide in the multi-modality treatment after surgery for cure for small-cell bronchial carcinomas (SCLC)
For the optimisation of the therapy for small cell bronchial carcinomas (SCLC), surgery is used to eliminate the primary tumor and its regional lymph nodes and chemo- and radiotherapy for the general treatment...
-
Article
Cancer therapy: new trends
-
Article
Plasma glutamate concentration and lymphocyte activity
Elevated glutamate concentrations are commonly observed in tumor patients, and glutamate was recently found to competitively inhibit the membrane transport of cystine. We therefore investigated the possibility...
-
Article
TNM stage, immunohistology, syntactic structure analysis and survival in patients with small cell anaplastic carcinoma of the lung
TNM stage, immunostaining with various monoclonal and polyclonal antibodies, analysis of distance of neighboring cells, remission rates, and survival were analyzed in 60 patients suffering from small cell anap...
-
Article
Ifosfamide in treatment of lung cancer
-
Article
A randomized trial for alternating polychemotherapy of small cell lung cancer
-
Article
Phase-1-clinical-study of 24 hour intravenous infusion of doxifluridine for 3 months